Magnitude and determinants of drug therapy problems among type 2 diabetes mellitus patients with hypertension in Ethiopia.

Kefale, Belayneh; Tegegne, Gobezie T; Kefale, Yitayih; Molla, Mulugeta; Ewunetei, Amien; Degu, Amsalu

Kefale, Belayneh; Tegegne, Gobezie T; Kefale, Yitayih; Molla, Mulugeta; Ewunetei, Amien; Degu, Amsalu.

Afiliación

Kefale B; Clinical Pharmacy Unit and Research Team, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Tegegne GT; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Kefale Y; Clinical Pharmacy Unit, Department of Pharmacy, Bahir Dar Health Sciences College, Bahir Dar, Ethiopia.
Molla M; Pharmacology Unit and Research team, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Ewunetei A; Pharmacology Unit and Research team, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Degu A; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy and Health Sciences, United States International University-Africa, Nairobi, Kenya.

SAGE Open Med ; 8: 2050312120954695, 2020.

Article en En | MEDLINE | ID: mdl-33029350

Palabras clave

Drug therapy problem; Ethiopia; hypertension; type 2 diabetes mellitus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: SAGE Open Med Año: 2020 Tipo del documento: Article País de afiliación: Etiopia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google